SynthesisClinical rheumatology2016

Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses.

Yuehong Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.